"Passionate about improving cattle health & welfare through innovation, excellence & valued & trusted customer support."

Metacam® Cattle

Metacam for Cattle is a non-steroidal anti-inflammatory drug (NSAID) which:

  • Reduces effects of toxaemia
  • Reduces swelling
  • Reduces fever
  • Relieves pain

A convenient single injection under the skin or into a vein, providing long-acting effects. It works by blocking the action of an enzyme, cyclo-oxygenase (COX), which is involved in the production of inflammatory chemicals. Metacam (meloxicam) is a COX-2 preferential NSAID which means it targets the inflammatory process with fewer side-effects.

Metacam Mastitis Calculator 

  Use the online calculator at www.mastitiscalculator.com

  to calculate the saving you could make using Metacam in

  all cases of mild to moderate mastitis.



   Also available for download from the App Store, click on the App Store icon below

Metacam Mastitis Calculator App


Metacam for cattle has proven benefits in:


  • Improved general condition, milk appearance and severity of swelling¹
  • Outperformed the short-acting NSAID, flunixin¹
  • Reduction in milk somatic cell count and culling rate following treatment of cases of mild to moderate mastitis2


  • Reduces temperature3
  • Improves weight gain3
  • Reduces severity of lung damage4

Calf Scour

  • Meloxicam is the only NSAID licensed for use in calf scour
  • Improved food intake and drinking5
  • Significantly increased calf weight gain5

Dehorning / Disbudding

  • Meloxicam is the only NSAID licensed for the relief of post-operative pain following dehorning in calves
  • Decreased pain response and improved well-being⁶
  • Increased weight gain post-dehorning⁷

Summary of the Mammary Study

Some of the most important proven benefits of Metacam, for its use in mild to moderate mastitis, were discovered in the Mammary Study2.

This was a study that looked at the effect of treatment with Metacam on milk production, somatic cell count, probability of re-treatment, and culling of dairy cows with mild clinical mastitis. It is the largest study of its kind ever undertaken, involving 727 dairy cows across 15 herds in New Zealand and it looked at a new treatment model of farmer–diagnosed mastitis.

The treatment involved Metacam + antibiotic (Penethamate hydriodide) vs. control vehicle (placebo) + antibiotic (Penethamate hydriodide).

SCC data supports the new treatment model2

Adjunctive use of Metacam (combined with an antibiotic) resulted in a significantly lower overall SCC in the Metacam treated group compared to the control vehicle and antibiotic group (p=0.001)2

Culling data supports the new treatment model2

Adjunctive use of Metacam (combined with an antibiotic) resulted in a highly significant 42% lower culling rate compared to the control vehicle and an antibiotic2

Final group cull rates were 16.4% for the Metacam + antibiotic group vs 28.2% for the control vehicle +antibiotic (p<0.001)

Improve your mastitis treatment protocol with the addition of long-acting Metacam

  • Metacam† reduces SCCs2
  • Metacam† reduces culling rates2
  • Metacam† improves cow health and welfare

Metacam solution for injection is also licensed for use in pigs and horses. 

For more information please see the Metacam Datasheet.


  1. Friton G et al (2002) World Buiatric Congress, Hannover, Germany
  2. McDougall et al (2009) J. Dairy Sci 92:4421-4431
  3. H. Schmidt et al (2000) XXI. World Buiatric Congress, Uruguay
  4. Friton G et al (2005) Veterinary Record 156:809-811
  5. Todd et al (2007) 41st ISAE, Mexico
  6. Heinrich et al (2010) J. Dairy Sci 93:2450-2457
  7. Coetzee JF et al (2012) BMC Vet Res 8 (1):153

An educational service from Boehringer Ingelheim Limited, Vetmedica Division, the makers of Metacam®, Bovikalc®, Ubrolexin®, Ubro Yellow®, Ubro Red® and Mamyzin®.

Advice on the use of Metacam, Bovikalc or other therapies should be sought from your veterinary surgeon. Metacam contains meloxicam, UK: POM-V IE: POM. Bovikalc contains calcium chloride and calcium sulphate and is not a veterinary medicine which is subject to authorisation by the Irish Medicines Board. Further information available from Boehringer Ingelheim Limited, Vetmedica Division, Bracknell, Berkshire, RG12 8YS, UK. Email: vetmedica.uk@boehringer-ingelheim.com | Web: www.boehringer-ingelheim.co.uk

See our Terms of Use

Date of preparation: Jul 2013. AHD 7729. Use Medicines Responsibly (www.noah.co.uk/responsible)